PharVision Advisers’s Lithium Americas LAC Stock Holding History

PharVision Advisers’s Portfolio LAC Stock Details LAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,569	Closed	-$169K	–	861
2025 Q3	$169K	Buy	+29,569	New	+$93.4K	0.1%	551

Other funds holding LAC

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

GMH

General Motors Holdings Detroit, Michigan $90.5M AUM 41.49% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's LAC Position: Q4 2025 in Review

PharVision Advisers sold out of Lithium Americas (LAC) in Q4 2025, closing a stake of 29,569 shares — an estimated $169K sold.

PharVision Advisers first reported a position in LAC in Q3 2025 and held it in 1 quarter. The position peaked at $169K in Q3 2025. 280 funds tracked by Wall St. Rank hold LAC as of Q4 2025.

PharVision Advisers reported no remaining Lithium Americas position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 29,569 Lithium Americas shares in Q4 2025, an estimated $169K.
PharVision Advisers first reported a position in Lithium Americas in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Lithium Americas position peaked at $169K in Q3 2025.
280 funds tracked by Wall St. Rank held Lithium Americas as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.